261
Participants
Start Date
December 27, 2018
Primary Completion Date
July 26, 2019
Study Completion Date
July 26, 2019
Netarsudil Ophthalmic Solution 0.02%
1 drop in each eye once daily in the evening
Scott & Christie and Associates, PC, Cranberry Township
Valley Eye Professionals, LLC, Huntingdon Valley
Glaucoma Consultants, Baltimore
Carolina Cataract & Laser Center, Ladson
Coastal Research Associates, LLC, Roswell
Shettle Eye Research Inc, Largo
Center For Sight, Sarasota
Advancing Vision Research, Nashville
Total Eye Care, PA, Memphis
VRF Eye Specialty Group, Memphis
Gaddie Eye Centers, LLC, Louisville
The Eye Centers of Racine and Kenosha, Racine
Wheaton Eye Clinic, Ltd, Wheaton
Tekwani Vision Center, St Louis
Stiles Eyecare Excellence and Glaucoma Institute, PA, Overland Park
Mark J. Weiss, M.D., Inc., Tulsa
Houston Eye Associates, Houston
Keystone Research, Austin
Cataract & Glaucoma Center, El Paso
Atlantis Eyecare, Huntington Beach
Harvard Eye Associates, Laguna Hills
North Bay Eye Associates, Inc, Petaluma
Lead Sponsor
Aerie Pharmaceuticals
INDUSTRY